Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schackert

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Neurology|December 22, 2010
Complementary therapy use in patients with glioma: an observational studyO Heese, M Schmidt, S Nickel, et al.
Acta Neuropathologica Communications|August 6, 2024
Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutationJ Steininger, C Buszello, R Oertel, et al.
The Journal of Investigative Dermatology|January 30, 2023
Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma MetastasesDana Westphal, Matthias Meinhardt, Konrad Grützmann, et al.
Acta Neuropathologica Communications|April 27, 2019
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and developmentH Binder, E Willscher, H Loeffler-Wirth, et al.
Journal of Neuro-Oncology|January 8, 2014
NDRG1 prognosticates the natural course of disease in WHO grade II gliomaJ Blaes, M Weiler, F Sahm, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Neurology|December 22, 2010
Complementary therapy use in patients with glioma: an observational studyO Heese, M Schmidt, S Nickel, et al.
Acta Neuropathologica Communications|August 6, 2024
Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutationJ Steininger, C Buszello, R Oertel, et al.
The Journal of Investigative Dermatology|January 30, 2023
Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma MetastasesDana Westphal, Matthias Meinhardt, Konrad Grützmann, et al.
Acta Neuropathologica Communications|April 27, 2019
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and developmentH Binder, E Willscher, H Loeffler-Wirth, et al.
Journal of Neuro-Oncology|January 8, 2014
NDRG1 prognosticates the natural course of disease in WHO grade II gliomaJ Blaes, M Weiler, F Sahm, et al.
Pageof 7